Live from the NIH registry
Studies recruiting near Denver right now
Top 25 of 1,600 recruiting studies, sorted by proximity — each links to its official registry page
UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 45 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: Nationwide Children's Hospital
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
Neuromyelitis Optica Spectrum Disorder, Pregnancy Related
N/A
Observational 60 participants sought
University of Colorado Denver — Aurora, Colorado (3.2 mi)
· Sponsor: Amgen
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
SCRI Denver Drug Development Unit — Denver, Colorado (6.0 mi)
· Sponsor: Acepodia Biotech, Inc.
Type 1 Diabetes REst for Metabolic Health
Type 1 Diabetes (T1D), Sleep Health
N/A
Interventional 50 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Denver, Colorado (6.0 mi)
· Sponsor: Dren Bio
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: St. Jude Children's Research Hospital
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma (EHE)
Phase 2
Interventional 41 participants sought
University of Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: Sarcoma Alliance for Research through Collaboration
Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis
N/A
Observational 380 participants sought
Children'S Hospital of Colorado — Denver, Colorado (6.0 mi)
· Sponsor: University of Colorado, Denver
Effects of High Altitude on AMPK Activation
Pregnancy, IUGR
N/A
Observational 84 participants sought
University of Colorado Denver Anschutz Medical Campus — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver
Mode of Exercise and Bone Biomarkers in Older Veterans
Aging, Musculoskeletal Diseases
N/A
Interventional 120 participants sought
Rocky Mountain Regional VA Medical Center, Aurora, CO — Aurora, Colorado (3.2 mi)
· Sponsor: VA Office of Research and Development
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
Phase 2
Interventional 38 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: Nationwide Children's Hospital
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma
Phase 2
Interventional 52 participants sought
Colorado Blood Cancer Institute — Denver, Colorado (6.0 mi)
· Sponsor: Irene Ghobrial, MD
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Colorado Denver — Aurora, Colorado (3.2 mi)
· Sponsor: Jaeb Center for Health Research
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Rocky Mountain Cancer Centers (RMCC) ( Site 8001) — Aurora, Colorado (3.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Aurora, Colorado (3.2 mi)
· Sponsor: Sameek Roychowdhury
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Barbara Davis Center for Childhood Diabetes — Aurora, Colorado (3.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
Human Immunodeficiency Virus (HIV) Infection
Phase 2
Interventional 84 participants sought
University of Colorado at Denver ( Site 0108) — Aurora, Colorado (3.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
Genetic Regulators of Bone Health That Are Unique to Vertebral Bone
Age-Related Osteoporosis
N/A
Observational 550 participants sought
Univeristy of Colorado Denver — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver
BeSMART Secure Storage Counseling in the Inpatient Setting
Firearm Injury, Safety Issues
N/A
Interventional 400 participants sought
Children's Hospital Colorado — Aurora, Colorado (3.2 mi)
· Sponsor: Vanderbilt University Medical Center
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Rocky Mountain Cancer Centers — Lone Tree, Colorado (14.5 mi)
· Sponsor: Allogene Therapeutics
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
HIV-1-infection, Frailty
Phase 2
Interventional 100 participants sought
University of Colorado - Anschutz Medical Campus — Aurora, Colorado (3.2 mi)
· Sponsor: Massachusetts General Hospital
Cannabidiol and Cannabis Concentrate Users
Cannabis Use Disorder
Phase 2
Interventional 120 participants sought
University of Colorado Anschutz Medical Campus — Aurora, Colorado (3.2 mi)
· Sponsor: University of Colorado, Denver
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
IgA Nephropathy
Phase 2
Interventional 25 participants sought
Clinical Research Site 330 — Denver, Colorado (6.0 mi)
· Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.